Cell-Free Dna In Maternal Plasma Tests - Non-invasive Prenatal Diagnostics Market
The global cell-free dna in maternal plasma tests non-invasive prenatal diagnostics market size was valued at US$ 838.9 million in 2020 and is estimated to grow at a compound annual growth rate (CAGR) of 10.9% from 2020 to 2027.
Related Statistics
Cell-free dna in maternal plasma tests - Non-invasive prenatal diagnostics market highlights
- The global cell-free dna in maternal plasma tests segment generated a revenue of USD 838.9 million in 2020 and is expected to reach USD 1,729.1 million by 2027.
- The market is expected to grow at a CAGR (2021 - 2027) of 11% by 2027.
- In terms of region, North America was the largest revenue generating market in 2020.
- Country-wise, China is expected to register the highest CAGR from 2021 to 2027.
Market summary
| Market revenue in 2020 | USD 838.9 million |
| Market revenue in 2027 | USD 1,729.1 million |
| Growth rate | 11% (CAGR from 2021 to 2027) |
| Historical data covered | 2015 - 2019 |
| Base year for estimation | 2020 |
| Forecast period covered | 2021 - 2027 |
| Quantitative units | Revenue in USD million |
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Non-invasive Prenatal Diagnostics Market Scope
Non-invasive prenatal diagnostics market segmentation & scope
Non-invasive Prenatal Diagnostics Market
- HTML
- PPT
- -
Everything on Non-invasive Prenatal Diagnostics Market in one document: edited and divided into chapters, including detailed references.
Related industry reports
Related Regional Reports
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
